Impact of the 13-valent conjugated pneumococcal vaccine on the direct costs of invasive pneumococcal disease requiring hospital admission in children aged < 5 years. A prospective study

Impact of the 13-valent conjugated pneumococcal vaccine on the direct costs of invasive pneumococcal disease requiring hospital admission in children aged < 5 years. A prospective study

The lack of invasive pneumococcal disease (IPD) cost studies may underestimate the effect of pneumococcal polysaccharide conjugated vaccines (PCV). The objective of this study was to estimate the direct costs of hospitalized IPD cases. A prospective study was made in children aged

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hernández, Sergi, Navas, Encarna, Aznar Lou, Ignacio, Ciruela, Pilar, García García, Juan José, Moraga Llop, Fernando A, Muñoz Almagro, Carmen, Codina Grau, Maria Gemma, de Sevilla, Mariona F, González Peris, Sebastià, Esteva, Cristina, Planes, Ana María, Izquierdo, Conchita, Martínez Osorio, Johanna, Campins Martí, Magda, Uriona, Sonia, Salleras i Sanmartí, Lluís, Serrano Blanco, Antoni, Jané, Mireia, Domínguez García, Àngela
Format: Artikel
Sprache:eng
Schlagworte:
Children
Infants
Pneumococcal vaccine
Vacuna antipneumocòccica
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The lack of invasive pneumococcal disease (IPD) cost studies may underestimate the effect of pneumococcal polysaccharide conjugated vaccines (PCV). The objective of this study was to estimate the direct costs of hospitalized IPD cases. A prospective study was made in children aged
ISSN:2076-393X
2076-393X
DOI:10.3390/vaccines8030387